Phillip Dan Cook

NUCLEOSIDE DERIVATIVES AS INHIBITORS OF RNA-DEPENDENT RNA VIRAL POLYERMASE

NUCLEOSIDE DERIVATIVES AS INHIBITORS OF RNA-DEPENDENT RNA VIRAL POLYMERASE

Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase

Composition and methods for the pulmonary delivery of nucleic acids

NOVEL TRICYCLIC NUCLEOSIDES OR NUCLEOTIDES AS THERAPEUTIC AGENTS

Compositions and methods for topical delivery of oligonucleotides

2'-Modified Oligonucleotides

Tricyclic nucleosides or nucleotides as therapeutic agents

2'-MODIFIED OLIGONUCLEOTIDES

Nucleoside derivatives as inhibitors of rna-dependent RNA viral polymerase

Tricyclic nucleosides or nucleotides as therapeutic agents

Oligonucleotdies having A-DNA form and B-DNA form conformational geometry

GAPPED 2' MODIFIED OLIGONUCLEOTIDES

GAPPED 2' MODIFIED OLIGONUCLEOTIDES

Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase

Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase

Oligonucleotides having A-DNA form and B-DNA form conformational geometry

Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase

Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase

Thionucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase

C3′ -methylene hydrogen phosphonate oligomers and related compounds

Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase

Methods of using mammalian RNase H and compositions thereof

Guanidinium functionalized intermediates

α-modified nucleoside triphosphates

Compositions and methods for topical delivery of oligonucleotides

Nucleosidic and non-nucleosidic folate conjugates

Compositions and methods for topical delivery of oligonucleotides